A case of Lactobacillus casei bacteraemia associated with aortic dissection: is there a link?

被引：0

作者：

Russo, Alessandro ^{[1
]}

Angeletti, Silvia ^{[4
]}

Lorino, Giulia ^{[2
]}

Venditti, Cecilia ^{[2
]}

Falcone, Marco ^{[3
]}

Dicuonzo, Giordano ^{[4
]}

Venditti, Mario ^{[3
]}

机构：

[1] Univ Roma La Sapienza, Dept Internal Med, Rome, Italy

[2] Univ Roma La Sapienza, Dept Publ Hlth Sci, Rome, Italy

[3] Univ Roma La Sapienza, Dept Infect Dis, Rome, Italy

[4] Inst Microbiol & Lab Med, Rome, Italy

来源：

NEW MICROBIOLOGICA | 2010年 / 33卷 / 02期

关键词：

Lactobacillus casei bacteraemia; Aortic dissection; Heavy dairy consumption; Intravascular infection; Low grade fever; Aortic wall defect; ENDOCARDITIS; VANCOMYCIN; AGENTS;

D O I：

暂无

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

We describe an unusual case of Lactobacillus casei bacteraemia in a heavy dairy consumer woman, with a one month history of low grade fever and admitted to our hospital for sudden onset of severe thoracic pain due to dissection of the aortic arch and ascending aorta. The patient underwent four weeks of intravenous ampicillin (2 g every 4 hours) followed by 2 weeks of oral amoxicillin (1 g every 8 hours) with resolution of fever, thoracic pain and progression of aortic disease. On the basis of the patient's symptoms, a possible penetration of L. casei in all aortic wall defect with development of aortic dissection is hypothesized.

引用

页码：175 / 178

页数：4

共 21 条

[1] Probiotic agents and infectious diseases: A modern perspective on a traditional therapy [J].

Alvarez-Olmos, MI ;

Oberhelman, RA .

CLINICAL INFECTIOUS DISEASES, 2001, 32 (11) :1567-1576

[2]

Antony S, 1998, CLIN INFECT DIS, V26, P1483, DOI 10.1086/517657

[3] LACTOBACILLEMIA - REPORT OF 9 CASES - IMPORTANT CLINICAL AND THERAPEUTIC CONSIDERATIONS [J].

BAYER, AS ;

CHOW, AW ;

BETTS, D ;

GUZE, LB .

AMERICAN JOURNAL OF MEDICINE, 1978, 64 (05) :808-813

[4] BACTERICIDAL SYNERGY BETWEEN PENICILLIN OR AMPICILLIN AND AMINOGLYCOSIDES AGAINST ANTIBIOTIC-TOLERANT LACTOBACILLI [J].

BAYER, AS ;

CHOW, AW ;

MORRISON, JO ;

GUZE, LB .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1980, 17 (03) :359-363

[5] Pathogenic relevance of Lactobacillus:: a retrospective review of over 200 cases [J].

Cannon, JP ;

Lee, TA ;

Bolanos, JT ;

Danziger, LH .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2005, 24 (01) :31-40

[6] Persistence of colonization of intestinal mucosa by a Probiotic strain, Lactobacillus casei subsp rhamnosus Lcr35, after oral consumption [J].

De Champs, C ;

Maroncle, N ;

Balestrino, D ;

Rich, C ;

Forestier, C .

JOURNAL OF CLINICAL MICROBIOLOGY, 2003, 41 (03) :1270-1273

[7] Outcomes of bacteremia in patients with cancer and neutropenia: Observations from two decades of epidemiological and clinical trials [J].

Elting, LS ;

Rubenstein, EB ;

Rolston, KVI ;

Bodey, GP .

CLINICAL INFECTIOUS DISEASES, 1997, 25 (02) :247-259

[8] In vitro activities of the new semisynthetic glycopeptide telavancin (TD-6424), vancomycin, daptomycin, linezolid, and four comparator agents against anaerobic gram-positive species and Corynebacterium spp. [J].

Goldstein, EJC ;

Citron, DM ;

Merriam, CV ;

Warren, YA ;

Tyrrell, KL ;

Fernandez, HT .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2004, 48 (06) :2149-2152

[9]

HARTY DWS, 1993, J GEN MICROBIOL, V139, P2945

[10] Guidelines on prevention, diagnosis and treatment of infective endocarditis - Executive summary [J].

Horstkotte, D ;

Follath, F ;

Gutschik, E ;

Lengyel, M ;

Oto, A ;

Pavie, A ;

Soler-soler, J ;

Thiene, G ;

von Graevenitz, A .

EUROPEAN HEART JOURNAL, 2004, 25 (03) :267-276

← 1 2 3 →